Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/56543
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChiva Blanch, Gemma-
dc.contributor.authorGiménez Bonafé, Pepita-
dc.contributor.authorLlaudó Vallmajor, Inés-
dc.contributor.authorTorras Ambròs, Joan-
dc.contributor.authorCruzado, Josep Ma.-
dc.contributor.authorPetriz, Jordi-
dc.contributor.authorCastaño Boldú, Esther-
dc.contributor.authorFranquesa, Marcella-
dc.contributor.authorHerrero Fresneda, Immaculada-
dc.contributor.authorTortosa i Moreno, Avelina-
dc.contributor.authorRama, Inés-
dc.contributor.authorBestard Matamoros, Oriol-
dc.contributor.authorGrinyó Boira, Josep M.-
dc.contributor.authorLloberas Blanch, Núria-
dc.date.accessioned2014-08-01T10:17:36Z-
dc.date.available2014-08-01T10:17:36Z-
dc.date.issued2009-11-25-
dc.identifier.issn1482-1826-
dc.identifier.urihttp://hdl.handle.net/2445/56543-
dc.description.abstractP-glycoprotein (Pgp), a protein codified by Multi Drug Resistance (MDR1) gene, has a detoxifying function and might influence the toxicity and pharmacokinetics and pharmacodynamics of drugs. Sampling strategies to improve Pgp studies could be useful to optimize the sensitivity and the reproducibility of efflux assays. This study aimed to compare Pgp expression and efflux activity by measuring Rhodamine123 (Rh123) retention in lymphocytes stored under different conditions, in order to evaluate the potential utility of any of the storing conditions in Pgp functionality. Our results show no change in protein expression of Pgp by confocal studies and Western blotting, nor changes at the mRNA level (qRT-PCR). No differences in Rh123 efflux by Pgp activity assays were found between fresh and frozen lymphocytes after 24 hours of blood extraction, using either of the two Pgp specific inhibitors (VP and PSC833). Different working conditions in the 24 hours post blood extraction do not affect Rh123 efflux. These results allow standardization of Pgp activity measurement in different individuals with different timing of blood sampling and in different geographic areas. _______________-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherCanadian Society for Pharmaceutical Sciences-
dc.relation.isformatofReproducció del document publicat a: http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/6263-
dc.relation.ispartofJournal of Pharmacy and Pharmaceutical Sciences, 2009, vol. 12, num. 3, p. 357-366-
dc.rightscc-by-sa (c) Chiva Blanch, Gemma et al., 2009-
dc.rights.urihttp://creativecommons.org/licenses/by-sa/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationLimfòcits-
dc.subject.classificationGlicoproteïnes-
dc.subject.classificationToxicitat dels medicaments-
dc.subject.otherLymphocytes-
dc.subject.otherGlycoproteins-
dc.subject.otherDrug toxicity-
dc.titleDifferent Storing and Processing Conditions of Human Lymphocytes do not Alter P-Glycoprotein Rhodamine 123 Efflux-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec576746-
dc.date.updated2014-08-01T10:17:36Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
576746.pdf659.92 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons